The American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) are the two largest societies in the world whose members comprise the major experts and professionals working in the field of reproductive medicine and embryology. These societies have never before had a joint scientific meeting. METHODSA 3-day meeting was planned and took place in March of 2012. The goal was to present and debate key topics, as well as modes of practice in reproductive medicine and to discuss recent developments in the field. RESULTSPresentations by members of ASRM and ESHRE were of three types: 'state of the art' lectures, 'back-to-back' presentations of two points of view and debates. CONCLUSIONS
For the first time, ASRM and ESHRE held a joint meeting where a special emphasis was given to presentations on the hottest topics in the field. Although different opinions and approaches sometimes exist on the two sides of the Atlantic, an appreciation and acceptance of these differences was evident, and there was more commonality than divergence of opinion.
"Policies and guidelines usually suggest application of eSET for good prognosis patients focusing on the female population under 35 –38 years of age (Cutting et al., 2008; Kresowik et al., 2011; Gianaroli et al., 2012). However, very high multiple pregnancy rates were also observed in Italy in the advanced maternal age (AMA) patient populations in 2011: 19.2 and 12.0% for females aged 35– 39 years and 40–42 years, respectively . "
"Our findings support the hypothesis that gene expression profiles correlate with outcome and present a tentative list of the differentially expressed genes. Elective transfer of a single embryo (SET) is increasingly recommended as best practice in IVF treatment (Maheshwari et al., 2011; Gianaroli et al., 2012), which requires a reliable assessment of embryo quality. Embryo selection is currently based on morphology (2011), and although morphology is correlated fairly closely with the reproductive potential, the inability reliably to predict embryo viability is often considered a main reason for the relatively low pregnancy rate following assisted reproduction treatment. "
"IUI is a choice in couples who have social, cultural or religious objections to IVF, in people who are unable to, or would find it very difficult to, have vaginal intercourse. Some authors recommended IUI cycle without COS as COS has been associated with an increased risk of multiple pregnancies and ovarian hyperstimulation syndrome (OHSS) (Gianaroli et al., 2012). However, in a meta-analysis on couples with unexplained subinfertility, COS in combination with IUI was shown to result in significantly higher pregnancy rate (PR) and live birth rate per couple when compared with IUI in the natural cycle (odds ratio ( "
[Show abstract][Hide abstract] ABSTRACT: STUDY QUESTION Is the treatment with recombinant FSH (rFSH) plus recombinant LH (rLH) more effective than highly purified (HP)-hMG in terms of ongoing pregnancy rate (PR) in women ≥35 years
of age undergoing intrauterine insemination (IUI) cycles?
Human Reproduction 11/2014; 30(1). DOI:10.1093/humrep/deu302 · 4.57 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.